Botulinum toxin benefits patients with adult neurogenic lower urinary tract dysfunction

Video

R. Corey O'Connor, MD, discusses findings from a recent study published in Neurourology and Urodynamics.

In this interview, R. Corey O'Connor, MD, discusses the recent Neurourology and Urodynamics paper, “Intradetrusor botulinum toxin injections (300 units) for the treatment of poorly compliant bladders in patients with adult neurogenic lower urinary tract dysfunction," for which he served as a study author. O'Connor is associate professor of urology at the Medical College of Wisconsin, Milwaukee.

More videos:

How do OAB patient education materials measure up?

Disposable ureteroscope reduces costs of care

Gender disparity seen with renal cell carcinoma management

Related Videos
Man talking with doctor, who is taking notes on a clipboard | Image Credit: © DragonImages - stock.adobe.com
Shaya Taghechian, MD, answers a question during a video interview
Jacqueline Zillioux, MD, answers a question during a Zoom video interview
Man talking with doctor, who is taking notes on a clipboard | Image Credit: © DragonImages - stock.adobe.com
Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
Olivia H. Chang, MD, MPH, FACOG, answers a question during a video interview
Leo Dreyfuss, MD, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.